Noom, a digital health company known for its weight loss programs, has recently made a groundbreaking announcement. The company will now be offering a compounded GLP-1 drug as part of its new weight loss product, starting at $149. This treatment will feature compounded semaglutide, the same active ingredient found in Novo Nordisk’s popular obesity and diabetes drugs Wegovy and Ozempic.
Expanding on their current offerings, Noom is joining a growing trend among digital health companies in providing compounded versions of medications as a more affordable option for consumers. This move comes at a time when demand for weight loss and diabetes drugs is on the rise. With the introduction of this new program, Noom aims to make weight loss more accessible and affordable to a wider range of individuals.
GLP-1 medications, like Wegovy and Ozempic, are part of a class of medications that mimic gut hormones to help reduce appetite and regulate blood sugar. These compounded versions offer a cost-effective alternative to the brand-name drugs, which can be quite expensive. While Wegovy and Ozempic can cost around $1,000 per month before insurance, the compounded versions offered by Noom come at a significantly lower price point.
“Our position is that more supply, especially at a reasonable price, is needed right now, not less,” said Noom CEO Geoff Cook in an interview with CNBC. By offering a more affordable option for weight loss medications, Noom aims to make a positive impact on the health and well-being of its users.
Benefits of Compounded GLP-1 Medications
One of the key advantages of compounded GLP-1 medications is their affordability. With the high cost of brand-name drugs like Wegovy and Ozempic, compounded versions offer a more budget-friendly option for individuals looking to manage their weight and improve their health.
Additionally, compounded medications can be customized to meet the specific needs of each individual. This personalized approach to treatment can lead to better outcomes and a more tailored experience for users. By working with an FDA-regulated compounding pharmacy, Noom ensures that the medication provided in their program meets the highest standards of quality and safety.
Program Details
Participants in the Noom GLP-1 RX program will pay $149 for the first month and $279 for subsequent months as the dose of their medication increases. The company is committed to providing ongoing support and guidance to help users achieve their weight loss goals. Through one-on-one coaching, access to psychology-based programming, and tools for tracking progress, Noom offers a comprehensive approach to weight loss that goes beyond just taking medication.
For individuals who may want to taper off the medication in the future, Noom provides a plan for gradually reducing the dosage. This process is overseen by obesity-trained doctors to ensure the safety and effectiveness of the transition. Noom also offers incentives for individuals who successfully maintain their weight loss after completing the program, such as a free year of Noom or substantial medication discounts.
Getting Started
To enroll in the Noom GLP-1 RX program, participants can fill out an intake form on the company’s website. A contracted, obesity-trained doctor will review the form and determine if the compounded medication is appropriate for the individual. If approved, the medication will be shipped to the participant’s door within a week.
Participants will receive guidance on how to administer the medication, as well as access to coaching and support through the Noom platform. With a focus on long-term success, Noom provides tools and resources to help users maintain their weight loss and develop healthy habits for the future.
In conclusion, Noom’s launch of the GLP-1 RX program represents a significant step forward in the field of weight loss and health management. By offering a more affordable and accessible option for individuals seeking to improve their health, Noom is empowering users to take control of their well-being and achieve lasting results. With a focus on personalized care, ongoing support, and sustainable outcomes, Noom is setting a new standard for digital health companies in the weight loss industry.
